Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases, Cystic

Explore clinical trials studying Kidney Diseases, Cystic. Study availability and eligibility vary by location and protocol.

173 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases, Cystic trial results

Completed

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

NCT02160145

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Chronic Disease, +19 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Phoenix, Arizona, United States
View all 230 locations
View Trial Details
Completed

Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD

NCT01210560

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • Tufts-New England Medical Center Boston, Massachusetts, United States
  • Davita Clinical Research Minneapolis, Minnesota, United States
  • Mayo Medical Center Rochester, Minnesota, United States
  • University Hospitals of Cleveland/Case Cleveland, Ohio, United States
View Trial Details
Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency

NCT01377246

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +13 more
Locations
  • Ospedale San giovanni di Dio Agrigento, AG, Italy
  • Clinical Research Center fo Rare Diseases Aldo and Cele Daccò Ranica, Bergamo, Italy
  • Hospital "Vito Fazzi" Lecce, Italy
  • Hospital "Ospedale Maggiore policlinico, Mangiagalli e Regina elena" Milan, Italy
View Trial Details
Completed

Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease

NCT01039987

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • University of Alabama-Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • University of Kansas Kansas City, Kansas, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT00413777

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +11 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Univerisity of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Completed

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT00428948

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +12 more
Locations
  • Coastal Clinical Research Mobile, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • Apex Research of Riverside Riverside, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 133 locations
View Trial Details

Related conditions